The therapeutic potential of nanobodies

I Jovčevska, S Muyldermans - BioDrugs, 2020 - Springer
Today, bio-medical efforts are entering the subcellular level, which is witnessed with the fast-
developing fields of nanomedicine, nanodiagnostics and nanotherapy in conjunction with …

Antibody structure and function: the basis for engineering therapeutics

ML Chiu, DR Goulet, A Teplyakov, GL Gilliland - Antibodies, 2019 - mdpi.com
Antibodies and antibody-derived macromolecules have established themselves as the
mainstay in protein-based therapeutic molecules (biologics). Our knowledge of the structure …

[HTML][HTML] Advances in antibody phage display technology

L Ledsgaard, A Ljungars, C Rimbault, CV Sørensen… - Drug Discovery …, 2022 - Elsevier
Phage display technology can be used for the discovery of antibodies for research,
diagnostic, and therapeutic purposes. In this review, we present and discuss key parameters …

CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels

CCS Chini, TR Peclat, GM Warner, S Kashyap… - Nature …, 2020 - nature.com
Decreased NAD+ levels have been shown to contribute to metabolic dysfunction during
aging. NAD+ decline can be partially prevented by knockout of the enzyme CD38. However …

ImmunoPET: concept, design, and applications

W Wei, ZT Rosenkrans, J Liu, G Huang, QY Luo… - Chemical …, 2020 - ACS Publications
Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Pharmacological inhibitors of the NLRP3 inflammasome

A Zahid, B Li, AJK Kombe, T Jin, J Tao - Frontiers in immunology, 2019 - frontiersin.org
Inflammasomes play a crucial role in innate immunity by serving as signaling platforms
which deal with a plethora of pathogenic products and cellular products associated with …

NLR immune receptor–nanobody fusions confer plant disease resistance

J Kourelis, C Marchal, A Posbeyikian, A Harant… - Science, 2023 - science.org
Plant pathogens cause recurrent epidemics, threatening crop yield and global food security.
Efforts to retool the plant immune system have been limited to modifying natural components …

Antibody display technologies: selecting the cream of the crop

B Valldorf, SC Hinz, G Russo, L Pekar, L Mohr… - Biological …, 2022 - degruyter.com
Antibody display technologies enable the successful isolation of antigen-specific antibodies
with therapeutic potential. The key feature that facilitates the selection of an antibody with …

[PDF][PDF] Nanobody—A versatile tool for cancer diagnosis and therapeutics

M Liu, L Li, D Jin, Y Liu - Wiley Interdisciplinary Reviews …, 2021 - researchgate.net
In spite of the successful use of monoclonal antibodies (mAbs) in clinic for tumor treatment,
their applications are still hampered in therapeutic development due to limitations, such as …

Immunogenicity and humanization of single‐domain antibodies

MA Rossotti, K Bélanger, KA Henry… - The FEBS Journal, 2022 - Wiley Online Library
Single‐domain antibodies (sdAbs), the autonomous variable domains of camelid and shark
heavy‐chain antibodies, have many desirable properties as components of biologic drugs …